‘Abstract Expressionists: The Women’ Review: A Movement’s Underexplored Side

The Muscarelle Museum of Art takes an engaging, expansive approach to highlighting the often-overlooked female practitioners ...

Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026

The AACR 2026 conference will be held from April 17-22, 2026. The AACR plans to publish the abstract titles on March 17, 2026 at 4:30 pm EST, the abstracts on April 17, 2026 at 3:00 pm EST, and the ...
Yahoo Finance

BioVie Announces Abstracts Accepted for Presentation at the 2026 American College of Psychiatrists Annual Meeting

CARSON CITY, Nev., Feb. 12, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and ...
PharmiWeb

Chiesi Global Rare Diseases Reinforces Long-Term Commitment to the Rare Disease Community with Multiple Abstract Presentations at the 22nd Annual WORLDSymposium™

-- These scientific contributions in lysosomal storage disorders (LSDs) underscore a sustained investment in data generation, patient-centered research, and authentic rare disease representation -- ...
Finanznachrichten

Chiesi Global Rare Diseases Reinforces Long-Term Commitment to the Rare Disease Community with Multiple Abstract Presentations at the 22nd Annual WORLDSymposium

-- Chiesi's abstract presentations will focus on clinical insights and patient-reported outcomes inFabry disease and alpha-mannosidosis -- -- These scientific contributions in lysosomal storage ...
Mena FN

Chiesi Global Rare Diseases Reinforces Long-Term Commitment To The Rare Disease Community With Multiple Abstract Presentations At The 22Nd Annual Worldsymposiumtm

(MENAFN- GlobeNewsWire - Nasdaq) -- Chiesi's abstract presentations will focus on clinical insights and patient-reported outcomes in Fabry disease and alpha-mannosidosis -- -- These scientific ...
WATE 6 On Your Side

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings

Breadth of Scientific Evidence: The acceptance of 1 oral presentation, 5 digital oral presentations and 16 posters reflect an expanding dataset for obefazimod, including additional efficacy, safety, ...
Seeking Alpha

Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting

WILMINGTON, Del., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, today announced the publication ...
Morningstar

GlycoNex Abstract on Glycan-Directed ADC GNX1021 Accepted for Presentation at AACR-NCI-EORTC 2025

NEW TAIPEI CITY, Taiwan, Oct. 20, 2025 /PRNewswire/ -- GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed ...